Latest News

Macular Degeneration Research

A BrightFocus-funded research team has identified how an FDA-approved antioxidant may be used to help prevent age-related macular degeneration in people with certain genetic risk factors for the disease. 

Jul 10, 2023
Macular Degeneration Research

Factors that stress the body, such as obesity, can make people more likely to develop macular degeneration when they’re older, even if they’ve returned to a normal weight, new research shows.

May 31, 2023
Macular Degeneration Research

BrightFocus Foundation, an international nonprofit funder of brain and vision research, recognized five leading vision scientists for their ideas to prevent, treat, and cure macular degeneration and glaucoma during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).

Apr 27, 2023
Macular Degeneration Research

A recent study reveals that an anti-inflammatory drug approved to treat certain autoimmune diseases can counteract a protein in the body that’s linked to age-related macular degeneration. These findings may lead to a new treatment option for the disease.

Mar 10, 2023
Macular Degeneration Research

BrightFocus Foundation celebrates the U.S. Food and Drug Administration’s approval of Syfovre (pegcetacoplan injection), the first-ever treatment to slow the progression of vision loss from geographic atrophy, an advanced form of dry age-related macular degeneration and a leading cause of blindness.

Feb 17, 2023
Macular Degeneration Research

In recognition of Macular Degeneration Awareness Month this February, BrightFocus Foundation, a nonprofit dedicated to ending diseases of mind and sight, is offering a variety of free educational resources to help individuals with macular degeneration and their loved ones navigate the disease.

Feb 1, 2023
Macular Degeneration Research

The U.S. Food and Drug Administration in November granted Breakthrough Therapy designation for a new treatment that could slow the progression of geographic atrophy, an advanced and severe form of dry age-related macular degeneration that can lead to permanent vision loss. 

Jan 17, 2023
Macular Degeneration Research

David Liao, MD, offers insights into managing and understanding AMD and what forthcoming FDA approval could mean for treatment.

Nov 30, 2022
Macular Degeneration Research

If approved, the drug pegcetacoplan would become the first-ever treatment in the U.S. for geographic atrophy, a blinding and advanced form of age-related macular degeneration.

Nov 21, 2022
Macular Degeneration Research

In this issue:

  • President’s Corner
  • One-Time Gene Therapy for Wet AMD
  • DNA Modifcation and Gene Expression in AMD
  • And more!
Nov 9, 2022